You are here: Industry Insights > CHMP

News List

Novartis Receives CHMP Positive Opinion for Enerzair® Breezhaler americanpharmaceuticalreview
May 07, 2020
Novartis announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion.
Novartis receives CHMP positive opinion for Enerzair Breezhaler pharmaceutical-business-review
May 06, 2020
Novartis announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion.
CHMP puts eight new medicines forward for approval pharmatimes
May 06, 2020
The European Medicines Agency's human medicines committee (CHMP) has put forward eight medicines for approval at its April meeting.
EMA recommendations on compassionate use of remdesivir for COVID-19 europeanpharmaceuticalreview
April 07, 2020
The European Medicines Agency has released recommendations about which patients could benefit from remdesivir and the possible criteria for compassionate use of the drug.
Mylan, Lupin Announce Positive CHMP Opinion for Biosimilar Nepexto americanpharmaceuticalreview
April 01, 2020
Mylan and Lupin announced the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Nepexto® ...
CHMP backs eight new meds in virtual March meeting pharmatimes
March 31, 2020
Eight new medicines and six indication extensions have been recommended for approval at the European Medicines Agency’s (EMA) latests human medicines committee (CHMP).
Committee for Medicinal Products for Human Use (CHMP) meeting highlights europeanpharmaceuticalreview
March 31, 2020
A summary of the CHMP meeting conclusions, including medicines recommended for approval and indication extension and several safety review findings.
Novartis gets positive CHMP opinion for Zolgensma and Cosentyx pharmaceutical-technology
March 31, 2020
Novartis has received a positive opinion from the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) for Zolgensma in spinal muscular atrophy (SMA), and Cosentyx in non-radiographic axial spondyloarthritis (nr-axSpA).
CHMP gives Sanofi positive opinion for Sarclisa pharmatimes
March 30, 2020
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Sarclisa (isatuximab).
“Harmonised approach” promoted for COVID-19 treatment clinical trials europeanpharmaceuticalreview
March 20, 2020
The EMA has urged that the research community prioritise large randomised controlled studies for COVID-19 treatments and vaccines.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page